Patent · US Active

High affinity beta lactamase inhibitors

US9730913B2 · kind B2 · utility

0Cited by

2References

45Claims

0Family size

Assignee

THE JOHNS HOPKINS UNIVERSITY · US

Inventors

Ernesto Freire · Baltimore, US
Rogelio Siles · Baltimore, US
Patrick C. Ross · College Park, US

Key dates

Filing date	Oct 12, 2012
Grant date	Aug 15, 2017
Priority date	—
Expiry date	Jan 27, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Inhibitors of beta lactamases and their use in treating bacterial infections are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.